India's CDSCO grants approval for Afrezza, an inhalable insulin spray, offering a needle-free alternative for diabetes management Afrezza provides a rapid, needle-free solution, ideal for patients ...

Hyperglycemia is a marker for poor clinical outcome and mortality in hospitalized patients. In the critical care setting, insulin administered intravenously or subcutaneously is effective.

Treatment for patients with Type 1 diabetes usually involves numerous daily injections of insulin to keep their blood glucose levels under control. This can be distressing and inconvenient.

They were originally developed to treat type 2 diabetes, which happens when the body’s cells become resistant to the hormone insulin. Some of them have also been found to be safe and effective ...

This marks the first successful application of such a therapy. In Type 1 diabetes, the immune system destroys insulin-producing cells in the pancreas (islets of Langerhans), leaving the body ...

A Japanese hospital said Monday it has completed a clinical test to transplant induced pluripotent stem cells that produce insulin to treat a patient with type 1 diabetes, in a step that could ease ...